Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Buy
2,452
+25
+1% +$2.93K 0.2% 67
2026
Q1
$292K Buy
2,427
+14
+0.6% +$1.62K 0.21% 64
2025
Q4
$254K Buy
2,413
+116
+5% +$10.9K 0.18% 74
2025
Q3
$193K Sell
2,297
-92
-4% -$7.58K 0.14% 84
2025
Q2
$189K Sell
2,389
-205
-8% -$16.3K 0.14% 86
2025
Q1
$233K Sell
2,594
-297
-10% -$27.7K 0.18% 73
2024
Q4
$288K Buy
+2,891
New +$298K 0.22% 68

Other funds holding MRK

Asset Planning Inc's MRK Position: Q2 2026 in Review

Asset Planning Inc increased its Merck (MRK) stake by 1% in Q2 2026, buying an estimated $2.93K and bringing the position to 2,452 shares worth $315K. The position accounts for 0.2% of the portfolio, ranked #67.

Asset Planning Inc first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Asset Planning Inc held 2,452 shares of Merck worth $315K as of Q2 2026.
  • Asset Planning Inc bought 25 Merck shares in Q2 2026, an estimated $2.93K.
  • Merck made up 0.2% of Asset Planning Inc's portfolio in Q2 2026, its #67 holding.
  • Asset Planning Inc first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Asset Planning Inc's 13F filing for Q2 2026, filed 27 Jul 2026.